Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
30
FLGC Quote, Financials, Valuation and Earnings
Last price:
$0.62
Seasonality move
:
21.76%
Day range:
$0.63 - $0.69
52-week range:
$0.42 - $2.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
3.03x
Volume:
117K
Avg. volume:
110.5K
1-year change:
-45.81%
Market cap:
$14.4M
Revenue:
$59.5M
EPS (TTM):
-$0.98
Analysts' Opinion
-
Consensus RatingFlora Growth has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2.75, Flora Growth has an estimated upside of 330.09% from its current price of $0.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.50 representing 100% downside risk from its current price of $0.64.
Fair Value
-
According to the consensus of 1 analyst, Flora Growth has 330.09% upside to fair value with a price target of $2.75 per share.
FLGC vs. S&P 500
-
Over the past 5 trading days, Flora Growth has overperformed the S&P 500 by 0.63% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Flora Growth does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Flora Growth revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Flora Growth reported revenues of $11.8M.
Earnings Growth
-
Flora Growth has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Flora Growth reported earnings per share of -$0.04.
Enterprise value:
15.1M
EV / Invested capital:
--
Price / LTM sales:
0.18x
EV / EBIT:
--
EV / Revenue:
0.28x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.33x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$11.5M
Return On Assets:
-50.25%
Net Income Margin (TTM):
-24.96%
Return On Equity:
-256.92%
Return On Invested Capital:
-166.05%
Operating Margin:
-17.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $48.5M | $74.8M | $53.3M | $18M | $11.8M | |
| Gross Profit | $16.4M | $16.2M | $11.5M | $3.9M | $2.9M | |
| Operating Income | -$16.5M | -$9.8M | -$13.5M | -$1.5M | -$2M | |
| EBITDA | -$14.3M | -$13.6M | -$12.9M | -$3.2M | -$487K | |
| Diluted EPS | -$11.96 | -$7.62 | -$0.98 | -$0.38 | -$0.04 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $27.9M | $21.8M | $13.2M | |
| Total Assets | -- | -- | $77M | $24.3M | $22.4M | |
| Current Liabilities | -- | -- | $15.5M | $19.3M | $12.6M | |
| Total Liabilities | -- | -- | $23.4M | $21.1M | $17.6M | |
| Total Equity | -- | -- | $53.6M | $3.1M | $4.8M | |
| Total Debt | -- | -- | $1.1M | $3.1M | $4.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$13.7M | -$5.4M | -$6.4M | -$1.3M | -$2.7M | |
| Cash From Investing | -$260K | -$220K | $728K | -$88K | $437K | |
| Cash From Financing | $4.2M | $4.4M | $5.3M | $1.2M | -- | |
| Free Cash Flow | -$14.9M | -$5.6M | -$6.5M | -$1.4M | -$2.8M | |
FLGC
Sector
Market Cap
$14.4M
$249.4M
Price % of 52-Week High
30.3%
75%
Dividend Yield
0%
0%
Shareholder Yield
--
2.89%
1-Year Price Total Return
-45.81%
-10.33%
Beta (5-Year)
--
0.377
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.65
200-day SMA
Sell
Level
$0.97
Bollinger Bands (100)
Sell
Level
0.55 - 0.73
Chaikin Money Flow
Buy
Level
210.7K
20-day SMA
Sell
Level
$0.65
Relative Strength Index (RSI14)
Sell
Level
47.89
ADX Line
Buy
Level
33.32
Williams %R
Neutral
Level
-57.2662
50-day SMA
Sell
Level
$0.66
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
237.9K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-7.6003)
Sell
CA Score
(Annual)
Level (-3.6871)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (8.2947)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
Stock Forecast FAQ
In the current month, FLGC has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FLGC average analyst price target in the past 3 months is $2.75.
-
Where Will Flora Growth Stock Be In 1 Year?
According to analysts, the consensus estimate is that Flora Growth share price will rise to $2.75 per share over the next 12 months.
-
What Do Analysts Say About Flora Growth?
Analysts are divided on their view about Flora Growth share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Flora Growth is a Sell and believe this share price will drop from its current level to $1.50.
-
What Is Flora Growth's Price Target?
The price target for Flora Growth over the next 1-year time period is forecast to be $2.75 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FLGC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Flora Growth is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of FLGC?
You can purchase shares of Flora Growth via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Flora Growth shares.
-
What Is The Flora Growth Share Price Today?
Flora Growth was last trading at $0.62 per share. This represents the most recent stock quote for Flora Growth. Yesterday, Flora Growth closed at $0.64 per share.
-
How To Buy Flora Growth Stock Online?
In order to purchase Flora Growth stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
